Cash Runway
Biotech Finance
Cash runway is the length of time a company can keep operating before it exhausts its cash, calculated from its cash balance and quarterly burn rate. For pre-revenue biotech it is a critical risk metric, since a short runway often forces dilutive financing.
Related terms
Learn more
Track Cash Runway across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free